NIH-funded research R01 grant

Pesticide exposure, brain inflammation, and Parkinson-like damage in aging

Official title: Mechanisms of pesticide-induced neuroinflammation and parkinsonism in aging mice

Funded at University of New England · NIH-11328992 · Data updated 2026-11-12

This research tests whether pesticide exposure triggers brain inflammation that leads to Parkinson-like nerve cell damage in aging people and those with past pesticide contact.

More Aging research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of New England
NIH-funded
Lab location1 site (Biddeford, United States)
Project startFebruary 9, 2022
Project endNovember 30, 2026
Funding year2026
Award (this year)$360,560
NIH project number5R01ES024745-11
Project IDNIH-11328992 on NIH RePORTER

Who could benefit from this research

Could help

People with Parkinson’s disease, older adults, and individuals with a history of regular pesticide exposure (for example agricultural workers) would be the most relevant candidates for related human sampling or follow-up studies.

Less likely to help

People without Parkinson’s and no history of pesticide exposure are unlikely to receive direct benefit from this specific project.

What this research studies

Researchers expose aging mice to pesticides linked to Parkinson’s disease to see if a specific inflammation switch (the NLRP3 inflammasome) turns on in brain cells. They compare normal mice with mice that lack this inflammasome to see if removing it prevents nerve cell loss. The team measures brain and blood markers and compares those findings to samples from people with Parkinson’s disease. The work aims to connect environmental exposures and genetic inflammation pathways to the kinds of brain changes seen in Parkinson’s.

Why it matters

Potential benefit: If successful, this work could point to new anti-inflammatory targets (like NLRP3) or blood markers that help prevent or slow Parkinson’s linked to toxic exposures.

How similar studies have gone: Prior animal and patient-sample work from this team and others links NLRP3 to Parkinsonian damage and shows NLRP3 loss can protect mice, and NLRP3-targeting approaches are now being explored clinically.

Where this research is happening

  • University of New England
    Biddeford, United States
    Active

Researchers

  • Principal investigator: Havrda, Matthew Charles — University of New England
  • Study coordinator: Havrda, Matthew Charles

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.